Melissa officinalis essential oil reduces plasma Triglycerides in human apolipoprotein E2 transgenic mice by inhibiting sterol regulatory element-binding protein-1c-dependent fatty acid synthesis

Journal of Nutrition

Volumn 142, Issue 3, 2012, Pages 432-440

  Jun, Hee jin ^a   Lee, Ji Hae ^a   Jia, Yaoyao ^a   Hoang, Minh Hien ^a   Byun, Hanna ^a   Kim, Kyoung Heon ^a   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; APOLIPOPROTEIN E2; CHOLESTEROL; ESSENTIAL OIL; FAS ANTIGEN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; LYSINE; MELISSA OFFICINALIS EXTRACT; PALMITIC ACID C 11; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTOME; TRIACYLGLYCEROL;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID SYNTHESIS; CELL STIMULATION; CHEMICAL COMPOSITION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FEEDING; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID LIVER LEVEL; LIVER CELL; MALE; MELISSA OFFICINALIS; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN E2; CHOLESTEROL; FATTY ACIDS; HEP G2 CELLS; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; LIVER; MALE; MELISSA; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHYTOTHERAPY; PLANT OILS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTOME; TRIGLYCERIDES;

MELISSA OFFICINALIS; MUS; MUS MUSCULUS;

EID: 84863229848     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.152538     Document Type: Article

References (50)

1. Holmes DR Jr, Elveback LR, Frye RL, Kottke BA, Ellefson RD. Association of risk factor variables and coronary artery disease documented with angiography. Circulation. 1981;63:293-9.
2. Stohler R, Keller U, Riesen WF. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. Eur J Clin Pharmacol. 1989;37:199-203.
3. Drexel H. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients? Fundam Clin Pharmacol. 2009;23:687-92.
4. Blane GF. Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med. 1987;83:26-36.
5. Morgan JM, Capuzzi DM, Guyton JR. A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am J Cardiol. 1998;82:U29-34; discussion U39-41.
6. Vergès B. Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD. Curr Opin Lipidol. 2006;17:653-8.
7. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:B7-12.
8. Chung MJ, Park KW, Kim KH, Kim CT, Baek JP, Bang KH, Choi YM, Lee SJ. Asian plantain (Plantago asiatica) essential oils suppress 3-hydroxy-3-methyl-glutaryl-co-enzyme A reductase expression in vitro and in vivo and show hypocholesterolaemic properties in mice. Br J Nutr. 2008;99:67-75.
9. Chung MJ, Cho SY, Bhuiyan MJ, Kim KH, Lee SJ. Anti-diabetic effects of lemon balm (Melissa officinalis) essential oil on glucose- and lipidregulating enzymes in type 2 diabetic mice. Br J Nutr. 2010;104:180-8.
10. Chung MJ, Kang AY, Park SO, Park KW, Jun HJ, Lee SJ. The effect of essential oils of dietary wormwood (Artemisia princeps), with and without added vitamin E, on oxidative stress and some genes involved in cholesterol metabolism. Food Chem Toxicol. 2007;45:1400-9.
11. Bisset NG, Wichtl M, editors. Herbal drugs and phytopharmaceuticals. Boca Raton, London, New York, Washington DC: CRC Press; 2001.
12. Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study. J Ethnopharmacol. 2005;99:391-8.
13. Hohmann J, Zupko I, Redei D, Csanyi M, Falkay G, Mathe I, Janicsak G. Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med. 1999;65:576-8.
14. Carnat APFD, Lamaison JL. The aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. subsp. officinalis) tea. Pharm Acta Helv. 1998;72:301-5.
15. Mulkens A, Stephanou E, Kapetenadis I. Heterosides a genines volatiles dans les feuilles de Melissa officinalis L. (lamiaceae). Pharm Acta Helv. 1985;60:276-8.
16. Clegg RJ, Middleton B, Bell GD, White DA. The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem. 1982;257:2294-9.
17. Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T, Mewes HW, Wichmann HE, Weinberger KM, Adamski J, et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 2008;4:e1000282.
18. Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res. 2002;43:1809-17.
19. MacBeath G. Protein microarrays and proteomics. Nat Genet. 2002;32 Suppl:526-32.
20. Elliott R, Ong TJ. Nutritional genomics. BMJ. 2002;324:1438-42.
21. Daniel H. Genomics and proteomics: importance for the future of nutrition research. Br J Nutr. 2002;87 Suppl 2:S305-11.
22. Sullivan PM, Mezdour H, Quarfordt SH, Maeda N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2. J Clin Invest. 1998;102:130-5.
23. Jun HJ, Kim S, Dawson K, Choi DW, Kim JS, Rodriguez RL, Lee SJ. Effects of acute oral administration of vitamin C on the mouse liver transcriptome. J Med Food. 2011;14:181-94.
24. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK. A comparison of background correction methods for twocolour microarrays. Bioinformatics. 2007;23:2700-7.
25. YangYH, Dudoit S, Luu P, LinDM, PengV, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002;30:e15.
26. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-93.
27. Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxietylike reactivity and on circadian and exploratory activities in mice. Phytomedicine. 2010;17:397-403.
28. Furth EE, Sprecher H, Fisher EA, Fleishman HD, Laposata M. An in vitro model for essential fatty acid deficiency: HepG2 cells permanently maintained in lipid-free medium. J Lipid Res. 1992;33:1719-26.
29. Natali F, Siculella L, Salvati S, Gnoni GV. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. J Lipid Res. 2007;48:1966-75.
30. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125-31.
31. Lindén D, William-Olsson L, Rhedin M, Asztely AK, Clapham JC, Schreyer S. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J Lipid Res. 2004;45:1279-88.
32. Fujimoto Y, Onoduka J, Homma KJ, Yamaguchi S, Mori M, Higashi Y, Makita M, Kinoshita T, Noda J, Itabe H, et al. Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase. Biol Pharm Bull. 2006;29: 2174-80.
33. Muchtaridi, Subarnas A, Apriyantono A, Mustarichie R. Identification of compounds in the essential oil of nutmeg seeds (Myristica fragrans Houtt.) that inhibit locomotor activity in mice. Int J Mol Sci. 2010;11:4771-81.
34. Muchtaridi DA, Subarnas A. Analysis of Indonesian spice essential oil compounds that inhibit locomotor activity in mice. Pharmaceuticals (Ott). 2011;4:590-602.
35. Kennedy DO, Scholey AB, Tildesley NT, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002;72:953-64.
36. Koch-Heitzmann I, SchultzeW. Melissa officinalis - von der Bienenpflanze zum Virustatikum. Z Phytother. 1984;9:77-85.
37. Kohan AB, Qing Y, Cyphert HA, Tso P, Salati LM. Chylomicron remnants and nonesterified fatty acids differ in their ability to inhibit genes involved in lipogenesis in rats. J Nutr. 2011;141:171-6.
38. Eberlé D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839-48.
39. Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest. 2004;113:1168-75.
40. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 2002;110:489-500.
41. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331-40.
42. Goldstein JL, Rawson RB, Brown MS. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys. 2002; 397:139-48.
43. Matsuda M, Korn BS, Hammer RE, Moon YA, Komuro R, Horton JD, Goldstein JL, Brown MS, Shimomura I. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. 2001;15: 1206-16.
44. Qin X, Xie X, Fan Y, Tian J, Guan Y, Wang X, Zhu Y, Wang N. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice. Hepatology. 2008;48:432-41.
45. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM. Regulation of hormoneinduced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 1999;98:675-86.
46. Li T, Chanda D, Zhang Y, Choi HS, Chiang JY. Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes. J Lipid Res. 2010;51:832-42.
47. Toth JI, Datta S, Athanikar JN, Freedman LP, Osborne TF. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Mol Cell Biol. 2004;24:8288-300.
48. Ericsson J, Edwards PA. CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription. J Biol Chem. 1998;273:17865-70.
49. Näär AM, Beaurang PA, Zhou S, Abraham S, Solomon W, Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 1999;398:828-32.
50. Bennett MK, Osborne TF. Nutrient regulation of gene expression by the sterol regulatory element binding proteins: increased recruitment of gene-specific coregulatory factors and selective hyperacetylation of histone H3 in vivo. Proc Natl Acad Sci USA. 2000;97:6340-4.